Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2006-10-05

FDA Approved: IBUPROFEN (NSAID) PAIN RELEIVER/ FEVER REDUCER — Supplemental Application (Amneal Pharmaceuticals of New York LLC)

View source ↗

Summary

FDA approved a supplemental application for Amneal's ibuprofen pain reliever/fever reducer, expanding/confirming its labeling and regulatory status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ibuprofen pain reliever/fever reducer (Ibuprofen)

Snippet

SUPPL AP for IBUPROFEN (NSAID) PAIN RELEIVER/ FEVER REDUCER (IBUPROFEN)